职位描述

　　Job Title: Senior Antibody researcher

　　Reports To: Senior Manager of project management team

　　Location: Hangzhou

　　Position Summary:

　　The senior antibody researcher will be responsible for development of RabMAb with best in class quality of researching hotspot and frontier targets to help our customer discover more.

　　Essential Job Functions:

　　 Immunogen designing based on database and target info.

　　 Study on target info based on published papers, datasheet of commercialize available antibody and Swiss-prot, etc.

　　 Antibody screening experimental designing includes WB, ICC, IHC, IP and Flow, etc. based on targets information and analysis the results tested by corresponding antibody screening technician.

　　 Make decisions about how to move the development forward into next step.

　　 Responsible for the whole process of antibody development until publication.

　　Minimum Requirements/Qualifications

　　• Rigorous academic trainings in cell biology and >=5 years’ hands-on experiences in the study of cell signaling pathways.

　　• More than 3 years experiences and able to do trouble shooting on following laboratory techniques: IHC, ChIP, ELISA, IF/ICC, flow cytometry, western blot, etc.

　　• Excellent reading and writing in English with good oral English

　　• Ability to rigorous logical thinking.

　　• Skillful communication with colleagues and teamwork guidance.

　　• Active and initiative work attitude for making progress relative independently.

　　• Strong willingness to contribute to bio-industry and help scientists discover more.

　　Education Qualifications:

　　• Minimal master degree in life sciences required. PhD or Post Doc Preferred. Education abroad a plus.

公司介绍

　　作为世界著名的抗体王国, abcam以优质、齐全的产品、完善的网络支持功能和强大的技术支持队伍得到全球客户的认可和赞誉。abcam成立于1998年，坐落于英国剑桥科技园区，并于2005年在伦敦证交所上市。至今，abcam在剑桥、旧金山、尤金、布里斯托尔、香港、东京、上海和杭州均设有分公司。

　　我们所拥有的兔单克隆抗体(RabMAb)专利技术，是继鼠单克隆抗体技术获得诺贝尔奖之后取得的重大突破。作为abcam兔单抗的研发和生产基地，宜康拥有的5000多个高质量抗体已销售全球市场，其中有200多个用于临床肿瘤诊断。这些抗体为科研人员和医务人员研究和寻找治疗方法提供了更有效的工具。另外，宜康为广大生物技术公司和药厂提供优质的抗体技术服务，帮助他们研发出具有高药效、低副作用的新药，造福人类健康。